Share Price and Basic Stock Data
Last Updated: February 27, 2025, 2:52 pm
PEG Ratio | 0.67 |
---|
Competitors of CreditAccess Grameen Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Muthoot Microfin Ltd | 2,294 Cr. | 135 | 258/131 | 7.69 | 176 | 0.00 % | 15.0 % | 20.4 % | 10.0 |
Satin Creditcare Network Ltd | 1,631 Cr. | 148 | 275/134 | 5.58 | 230 | 0.00 % | 16.6 % | 21.6 % | 10.0 |
CreditAccess Grameen Ltd | 16,099 Cr. | 1,009 | 1,553/750 | 18.3 | 438 | 0.94 % | 14.8 % | 24.8 % | 10.0 |
Industry Average | 6,674.67 Cr | 430.67 | 10.52 | 281.33 | 0.31% | 15.47% | 22.27% | 10.00 |
Quarterly Result
Metric | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 440 | 607 | 510 | 510 | 576 | 694 | 621 | 812 | 908 | 1,065 | 1,170 | 1,247 | 1,292 |
Interest | 179 | 186 | 196 | 183 | 192 | 217 | 226 | 273 | 314 | 346 | 385 | 424 | 442 |
Expenses | 351 | 317 | 268 | 224 | 206 | 267 | 209 | 299 | 293 | 311 | 309 | 342 | 365 |
Financing Profit | -91 | 104 | 46 | 103 | 177 | 210 | 186 | 240 | 301 | 409 | 477 | 481 | 486 |
Financing Margin % | -21% | 17% | 9% | 20% | 31% | 30% | 30% | 30% | 33% | 38% | 41% | 39% | 38% |
Other Income | 0 | 2 | 1 | 0 | 1 | 0 | 0 | 2 | 2 | 1 | 1 | 1 | 3 |
Depreciation | 5 | 7 | 6 | 6 | 6 | 7 | 7 | 13 | 13 | 12 | 12 | 12 | 13 |
Profit before tax | -95 | 99 | 41 | 97 | 172 | 203 | 179 | 229 | 290 | 398 | 465 | 469 | 476 |
Tax % | 25% | 27% | 27% | 26% | 25% | 25% | 26% | 24% | 26% | 25% | 26% | 26% | 26% |
Net Profit | -72 | 72 | 30 | 72 | 129 | 151 | 133 | 175 | 216 | 297 | 346 | 349 | 353 |
EPS in Rs | -4.61 | 4.65 | 1.90 | 4.62 | 8.29 | 9.71 | 8.50 | 11.22 | 13.82 | 18.98 | 22.16 | 21.95 | 22.20 |
Gross NPA % | 6.84% | 4.38% | 8.12% | 7.18% | 5.50% | 3.12% | 1.73% | 1.48% | 0.89% | 0.77% | |||
Net NPA % | 0.47% | 0.27% | 0.24% |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for CreditAccess Grameen Ltd based on the most recent figures (Dec 2023) and their trends compared to the previous period:
- For Interest, as of Dec 2023, the value is ₹442.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹424.00 Cr. (Sep 2023) to ₹442.00 Cr., marking an increase of ₹18.00 Cr..
- For Expenses, as of Dec 2023, the value is ₹365.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹342.00 Cr. (Sep 2023) to ₹365.00 Cr., marking an increase of ₹23.00 Cr..
- For Other Income, as of Dec 2023, the value is ₹3.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1.00 Cr. (Sep 2023) to ₹3.00 Cr., marking an increase of ₹2.00 Cr..
- For Depreciation, as of Dec 2023, the value is ₹13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹12.00 Cr. (Sep 2023) to ₹13.00 Cr., marking an increase of ₹1.00 Cr..
- For Profit before tax, as of Dec 2023, the value is ₹476.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹469.00 Cr. (Sep 2023) to ₹476.00 Cr., marking an increase of ₹7.00 Cr..
- For Tax %, as of Dec 2023, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2023) which recorded 26.00%.
- For Net Profit, as of Dec 2023, the value is ₹353.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹349.00 Cr. (Sep 2023) to ₹353.00 Cr., marking an increase of ₹4.00 Cr..
- For EPS in Rs, as of Dec 2023, the value is ₹22.20. The value appears strong and on an upward trend. It has increased from ₹21.95 (Sep 2023) to ₹22.20, marking an increase of ₹0.25.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 62 | 88 | 146 | 278 | 464 | 708 | 871 | 1,282 | 1,683 | 2,028 | 2,669 | 3,487 | 4,241 |
Interest | 30 | 42 | 72 | 129 | 208 | 317 | 354 | 417 | 575 | 745 | 987 | 1,216 | 1,413 |
Expenses | 32 | 39 | 50 | 76 | 126 | 264 | 184 | 361 | 639 | 1,069 | 1,235 | 1,179 | 1,190 |
Financing Profit | -1 | 7 | 24 | 74 | 130 | 128 | 332 | 504 | 470 | 214 | 447 | 1,092 | 1,638 |
Financing Margin % | -1% | 7% | 16% | 26% | 28% | 18% | 38% | 39% | 28% | 11% | 17% | 31% | 39% |
Other Income | 0 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 3 | 81 | 64 | 3 |
Depreciation | 1 | 1 | 1 | 2 | 3 | 4 | 5 | 8 | 20 | 23 | 47 | 50 | 45 |
Profit before tax | -2 | 8 | 25 | 75 | 130 | 124 | 328 | 498 | 451 | 194 | 481 | 1,105 | 1,596 |
Tax % | -70% | -5% | 33% | 35% | 36% | 35% | 35% | 35% | 27% | 27% | 27% | 25% | |
Net Profit | -3 | 8 | 17 | 49 | 83 | 80 | 212 | 322 | 328 | 142 | 353 | 826 | 1,189 |
EPS in Rs | -1.17 | 2.00 | 3.14 | 6.68 | 11.41 | 9.37 | 16.54 | 22.41 | 22.75 | 9.15 | 22.65 | 52.87 | 75.73 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
Year | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 366.67% | 112.50% | 188.24% | 69.39% | -3.61% | 165.00% | 51.89% | 1.86% | -56.71% | 148.59% | 133.99% |
Change in YoY Net Profit Growth (%) | 0.00% | -254.17% | 75.74% | -118.85% | -73.00% | 168.61% | -113.11% | -50.02% | -58.57% | 205.30% | -14.60% |
CreditAccess Grameen Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 43% |
5 Years: | 32% |
3 Years: | 36% |
TTM: | 22% |
Compounded Profit Growth | |
---|---|
10 Years: | 56% |
5 Years: | 35% |
3 Years: | 117% |
TTM: | -35% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 3% |
3 Years: | 9% |
1 Year: | -34% |
Return on Equity | |
---|---|
10 Years: | 16% |
5 Years: | 15% |
3 Years: | 18% |
Last Year: | 25% |
Last Updated: Unknown
Balance Sheet
Last Updated: January 13, 2025, 3:52 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 40 | 53 | 73 | 73 | 86 | 128 | 144 | 144 | 156 | 156 | 159 | 159 | 159 |
Reserves | 71 | 154 | 303 | 387 | 605 | 1,309 | 2,222 | 2,525 | 3,479 | 4,011 | 4,948 | 6,411 | 6,829 |
Borrowings | 389 | 805 | 1,291 | 2,233 | 2,668 | 3,623 | 4,867 | 7,823 | 8,781 | 12,921 | 16,312 | 21,841 | 19,154 |
Other Liabilities | 44 | 46 | 60 | 115 | 205 | 53 | 126 | 170 | 281 | 394 | 439 | 435 | 470 |
Total Liabilities | 543 | 1,058 | 1,727 | 2,808 | 3,564 | 5,114 | 7,357 | 10,662 | 12,697 | 17,482 | 21,858 | 28,846 | 26,612 |
Fixed Assets | 3 | 3 | 4 | 11 | 12 | 16 | 25 | 87 | 101 | 629 | 599 | 609 | 628 |
CWIP | 0 | 0 | 2 | 0 | 3 | 1 | 2 | 3 | 1 | 3 | 4 | 5 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 661 | 663 | 1 | 455 | 1,439 | 1,303 |
Other Assets | 540 | 1,055 | 1,720 | 2,796 | 3,549 | 5,096 | 7,330 | 9,911 | 11,932 | 16,849 | 20,801 | 26,794 | 24,682 |
Total Assets | 543 | 1,058 | 1,727 | 2,808 | 3,564 | 5,114 | 7,357 | 10,662 | 12,697 | 17,482 | 21,858 | 28,846 | 26,612 |
Below is a detailed analysis of the balance sheet data for CreditAccess Grameen Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹159.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹159.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹6,829.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹6,411.00 Cr. (Mar 2024) to ₹6,829.00 Cr., marking an increase of ₹418.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹19,154.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from ₹21,841.00 Cr. (Mar 2024) to ₹19,154.00 Cr., marking a decrease of ₹2,687.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹470.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹435.00 Cr. (Mar 2024) to ₹470.00 Cr., marking an increase of ₹35.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹26,612.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹28,846.00 Cr. (Mar 2024) to ₹26,612.00 Cr., marking a decrease of ₹2,234.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹628.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹609.00 Cr. (Mar 2024) to ₹628.00 Cr., marking an increase of ₹19.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹5.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of ₹5.00 Cr..
- For Investments, as of Sep 2024, the value is ₹1,303.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,439.00 Cr. (Mar 2024) to ₹1,303.00 Cr., marking a decrease of ₹136.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹24,682.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹26,794.00 Cr. (Mar 2024) to ₹24,682.00 Cr., marking a decrease of ₹2,112.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹26,612.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹28,846.00 Cr. (Mar 2024) to ₹26,612.00 Cr., marking a decrease of ₹2,234.00 Cr..
However, the Borrowings (₹19,154.00 Cr.) are higher than the Reserves (₹6,829.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 32.00 | -350.00 | -755.00 | 75.00 | 124.00 | 262.00 | 181.00 | 357.00 | 632.00 | -7.00 | -11.00 | -15.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROE % | 10% | 10% | 17% | 20% | 14% | 20% | 17% | 13% | 5% | 9% | 18% | 25% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Axis Small Cap Fund | 1,642,957 | 1.34 | 216.13 | 479,898 | 2025-02-25 | 242.36% |
PGIM India Midcap Opportunities Fund | 1,036,700 | 1.46 | 136.38 | 479,898 | 2025-02-25 | 116.03% |
Axis Business Cycles Fund | 762,926 | 3.96 | 100.36 | 479,898 | 2025-02-25 | 58.98% |
UTI Mid Cap Fund | 635,409 | 0.93 | 83.59 | 479,898 | 2025-02-25 | 32.41% |
Tata Mid Cap Growth Fund - Regular Plan | 500,000 | 2.61 | 65.78 | 479,898 | 2025-02-25 | 4.19% |
Edelweiss Balanced Advantage Fund | 485,577 | 0.67 | 63.88 | 479,898 | 2025-02-25 | 1.18% |
Edelweiss Mid Cap Fund | 479,898 | 1.66 | 63.13 | 479,898 | 2025-02-25 | 0% |
SBI Magnum Equity ESG Fund | 446,073 | 1.17 | 58.68 | 479,898 | 2025-02-25 | -7.05% |
PGIM India Flexi Cap Fund | 427,900 | 0.97 | 56.29 | 479,898 | 2025-02-25 | -10.84% |
UTI Small Cap Fund | 420,147 | 1.74 | 55.27 | 479,898 | 2025-02-25 | -12.45% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 90.88 | 52.04 | 23.31 | 8.96 | 23.20 |
Diluted EPS (Rs.) | 90.41 | 51.82 | 23.22 | 8.90 | 23.00 |
Cash EPS (Rs.) | 93.93 | 55.12 | 25.94 | 11.28 | 24.71 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 412.22 | 321.37 | 261.50 | 244.01 | 197.46 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 412.22 | 321.37 | 261.50 | 244.01 | 197.46 |
Revenue From Operations / Share (Rs.) | 324.17 | 223.09 | 175.97 | 158.18 | 118.36 |
PBDIT / Share (Rs.) | 233.58 | 149.02 | 97.01 | 74.12 | 73.64 |
PBIT / Share (Rs.) | 230.37 | 145.89 | 93.98 | 71.29 | 72.22 |
PBT / Share (Rs.) | 121.67 | 69.56 | 30.84 | 11.60 | 32.06 |
Net Profit / Share (Rs.) | 90.72 | 51.98 | 22.91 | 8.45 | 23.30 |
NP After MI And SOA / Share (Rs.) | 90.72 | 51.98 | 23.29 | 8.61 | 23.16 |
PBDIT Margin (%) | 72.05 | 66.79 | 55.13 | 46.85 | 62.21 |
PBIT Margin (%) | 71.06 | 65.39 | 53.40 | 45.06 | 61.01 |
PBT Margin (%) | 37.53 | 31.18 | 17.52 | 7.33 | 27.08 |
Net Profit Margin (%) | 27.98 | 23.30 | 13.01 | 5.33 | 19.68 |
NP After MI And SOA Margin (%) | 27.98 | 23.30 | 13.23 | 5.44 | 19.57 |
Return on Networth / Equity (%) | 22.00 | 16.17 | 9.12 | 3.63 | 12.19 |
Return on Capital Employeed (%) | 55.27 | 44.89 | 26.05 | 19.76 | 27.58 |
Return On Assets (%) | 5.01 | 3.77 | 2.08 | 0.88 | 2.64 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.37 | 0.48 | 0.32 |
Total Debt / Equity (X) | 3.32 | 3.19 | 3.25 | 2.96 | 3.49 |
Asset Turnover Ratio (%) | 0.20 | 0.18 | 0.15 | 0.16 | 0.18 |
Current Ratio (X) | 1.26 | 1.26 | 1.41 | 1.52 | 1.35 |
Quick Ratio (X) | 1.26 | 1.26 | 1.41 | 1.52 | 1.35 |
Interest Coverage Ratio (X) | 2.15 | 1.95 | 1.54 | 1.24 | 1.83 |
Interest Coverage Ratio (Post Tax) (X) | 1.83 | 1.68 | 1.36 | 1.14 | 1.58 |
Enterprise Value (Cr.) | 43473.04 | 29417.68 | 24491.84 | 18992.64 | 13802.88 |
EV / Net Operating Revenue (X) | 8.41 | 8.30 | 8.93 | 7.72 | 8.10 |
EV / EBITDA (X) | 11.68 | 12.42 | 16.20 | 16.47 | 13.02 |
MarketCap / Net Operating Revenue (X) | 4.44 | 4.10 | 4.83 | 4.24 | 2.86 |
Price / BV (X) | 3.49 | 2.85 | 3.33 | 2.83 | 1.78 |
Price / Net Operating Revenue (X) | 4.44 | 4.10 | 4.83 | 4.24 | 2.86 |
EarningsYield | 0.06 | 0.05 | 0.02 | 0.01 | 0.06 |
After reviewing the key financial ratios for CreditAccess Grameen Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 90.88. This value is within the healthy range. It has increased from 52.04 (Mar 23) to 90.88, marking an increase of 38.84.
- For Diluted EPS (Rs.), as of Mar 24, the value is 90.41. This value is within the healthy range. It has increased from 51.82 (Mar 23) to 90.41, marking an increase of 38.59.
- For Cash EPS (Rs.), as of Mar 24, the value is 93.93. This value is within the healthy range. It has increased from 55.12 (Mar 23) to 93.93, marking an increase of 38.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 412.22. It has increased from 321.37 (Mar 23) to 412.22, marking an increase of 90.85.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 412.22. It has increased from 321.37 (Mar 23) to 412.22, marking an increase of 90.85.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 324.17. It has increased from 223.09 (Mar 23) to 324.17, marking an increase of 101.08.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 233.58. This value is within the healthy range. It has increased from 149.02 (Mar 23) to 233.58, marking an increase of 84.56.
- For PBIT / Share (Rs.), as of Mar 24, the value is 230.37. This value is within the healthy range. It has increased from 145.89 (Mar 23) to 230.37, marking an increase of 84.48.
- For PBT / Share (Rs.), as of Mar 24, the value is 121.67. This value is within the healthy range. It has increased from 69.56 (Mar 23) to 121.67, marking an increase of 52.11.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 90.72. This value is within the healthy range. It has increased from 51.98 (Mar 23) to 90.72, marking an increase of 38.74.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 90.72. This value is within the healthy range. It has increased from 51.98 (Mar 23) to 90.72, marking an increase of 38.74.
- For PBDIT Margin (%), as of Mar 24, the value is 72.05. This value is within the healthy range. It has increased from 66.79 (Mar 23) to 72.05, marking an increase of 5.26.
- For PBIT Margin (%), as of Mar 24, the value is 71.06. This value exceeds the healthy maximum of 20. It has increased from 65.39 (Mar 23) to 71.06, marking an increase of 5.67.
- For PBT Margin (%), as of Mar 24, the value is 37.53. This value is within the healthy range. It has increased from 31.18 (Mar 23) to 37.53, marking an increase of 6.35.
- For Net Profit Margin (%), as of Mar 24, the value is 27.98. This value exceeds the healthy maximum of 10. It has increased from 23.30 (Mar 23) to 27.98, marking an increase of 4.68.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 27.98. This value exceeds the healthy maximum of 20. It has increased from 23.30 (Mar 23) to 27.98, marking an increase of 4.68.
- For Return on Networth / Equity (%), as of Mar 24, the value is 22.00. This value is within the healthy range. It has increased from 16.17 (Mar 23) to 22.00, marking an increase of 5.83.
- For Return on Capital Employeed (%), as of Mar 24, the value is 55.27. This value is within the healthy range. It has increased from 44.89 (Mar 23) to 55.27, marking an increase of 10.38.
- For Return On Assets (%), as of Mar 24, the value is 5.01. This value is within the healthy range. It has increased from 3.77 (Mar 23) to 5.01, marking an increase of 1.24.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 3.32. This value exceeds the healthy maximum of 1. It has increased from 3.19 (Mar 23) to 3.32, marking an increase of 0.13.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.20. It has increased from 0.18 (Mar 23) to 0.20, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 24, the value is 1.26. This value is below the healthy minimum of 1.5. There is no change compared to the previous period (Mar 23) which recorded 1.26.
- For Quick Ratio (X), as of Mar 24, the value is 1.26. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.26.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 2.15. This value is below the healthy minimum of 3. It has increased from 1.95 (Mar 23) to 2.15, marking an increase of 0.20.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.83. This value is below the healthy minimum of 3. It has increased from 1.68 (Mar 23) to 1.83, marking an increase of 0.15.
- For Enterprise Value (Cr.), as of Mar 24, the value is 43,473.04. It has increased from 29,417.68 (Mar 23) to 43,473.04, marking an increase of 14,055.36.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 8.41. This value exceeds the healthy maximum of 3. It has increased from 8.30 (Mar 23) to 8.41, marking an increase of 0.11.
- For EV / EBITDA (X), as of Mar 24, the value is 11.68. This value is within the healthy range. It has decreased from 12.42 (Mar 23) to 11.68, marking a decrease of 0.74.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.44. This value exceeds the healthy maximum of 3. It has increased from 4.10 (Mar 23) to 4.44, marking an increase of 0.34.
- For Price / BV (X), as of Mar 24, the value is 3.49. This value exceeds the healthy maximum of 3. It has increased from 2.85 (Mar 23) to 3.49, marking an increase of 0.64.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.44. This value exceeds the healthy maximum of 3. It has increased from 4.10 (Mar 23) to 4.44, marking an increase of 0.34.
- For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 23) to 0.06, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CreditAccess Grameen Ltd:
- Net Profit Margin: 27.98%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 55.27% (Industry Average ROCE: 15.47%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 22% (Industry Average ROE: 22.27%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.83
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.26
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18.3 (Industry average Stock P/E: 10.52)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.32
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 27.98%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Microfinance Institutions | No.49, 46th Cross, 8th Block, Bengaluru Karnataka 560071 | info@cagrameen.in http://www.creditaccessgrameen.in |
Management | |
---|---|
Name | Position Held |
Mr. George Joseph | Chairman & Ind.Director |
Mr. Paolo Brichetti | Vice Chairman & Non Exe.Dire |
Mr. Udaya Kumar Hebbar | Managing Director & CEO |
Ms. Rekha Gopal Warriar | Independent Director |
Mr. Manoj Kumar | Independent Director |
Ms. Lilian Jessie Paul | Independent Director |
Mr. Sumit Kumar | Nominee Director |
Mr. Massimo Vita | Nominee Director |
FAQ
What is the latest intrinsic value of CreditAccess Grameen Ltd?
Let's break down CreditAccess Grameen Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 27 February 2025:
- Calculated Fair Value: ₹1605.20
- Current Market Price: ₹1,009.00
- Variance: 59.09% higher
This suggests CreditAccess Grameen Ltd is currently undervalued by 59.09%. For context:
- Market Cap: 16,099 Cr.
- 52-Week Range: 1,553/750
- Reserves (Sep 2024): 6,829 Cr
- Liabilities: 26,612 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of CreditAccess Grameen Ltd?
The Market Cap of CreditAccess Grameen Ltd is 16,099 Cr..
What is the current Stock Price of CreditAccess Grameen Ltd as on 27 February 2025?
The current stock price of CreditAccess Grameen Ltd as on 27 February 2025 is ₹1,009.
What is the High / Low of CreditAccess Grameen Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of CreditAccess Grameen Ltd stocks is 1,553/750.
What is the Stock P/E of CreditAccess Grameen Ltd?
The Stock P/E of CreditAccess Grameen Ltd is 18.3.
What is the Book Value of CreditAccess Grameen Ltd?
The Book Value of CreditAccess Grameen Ltd is 438.
What is the Dividend Yield of CreditAccess Grameen Ltd?
The Dividend Yield of CreditAccess Grameen Ltd is 0.94 %.
What is the ROCE of CreditAccess Grameen Ltd?
The ROCE of CreditAccess Grameen Ltd is 14.8 %.
What is the ROE of CreditAccess Grameen Ltd?
The ROE of CreditAccess Grameen Ltd is 24.8 %.
What is the Face Value of CreditAccess Grameen Ltd?
The Face Value of CreditAccess Grameen Ltd is 10.0.